NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its third quarter revenues rose 12 percent year over year, crediting its molecular diagnostics and international businesses as drivers of new growth.

For the three months ended July 1, the firm reported total revenues of $806.1 million, up from $717.4 million in Q3 2016, and beating the average Wall Street analyst estimate of $799.7 million. On a constant-currency basis, revenues increased 13 percent.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.